HELIX BIOPHARMA CORP (HBP.CA) Stock Cash Flow
Canada - Toronto Stock Exchange - TSX:HBP - CA4229102088 - Common Stock
2.34 CAD
+0.01 (+0.43%)
| 2025 (2025-7-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.21M | -9.26M | -6.29M | -6.56M | -8.04M | |||
| Depreciation Amortization | 10.00K | 14.00K | 13.00K | 12.00K | 199.00K | |||
| Change In Working Capital | 1.33M | 485.00K | 186.00K | -893.00K | -54.00K | |||
| Taxes Paid | -14.00K | N/A | N/A | N/A | N/A | |||
| Other non cash items | 31.00K | 3.55M | 564.00K | 935.00K | -1.41M | |||
| OPERATING CASH FLOW | -3.83M | -5.22M | -5.53M | -6.51M | -9.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.00K | -14.00K | -10.00K | N/A | 0.00 | |||
| Other Investing Activity | 19.00K | N/A | 5.00K | 0.00 | 2.02M | |||
| INVESTING CASH FLOW | 17.00K | -14.00K | -5.00K | 0.00 | 2.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -2.06M | 0.00 | 3.00M | |||
| Stock Issued/Repurchased | 2.80M | 5.51M | 4.15M | 6.21M | 3.56M | |||
| Other Financing Activity | N/A | 0.00 | 999.00K | N/A | 0.00 | |||
| FINANCING CASH FLOW | 2.80M | 5.51M | 3.09M | 6.21M | 6.56M | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | -9.00K | 52.00K | |||
| CHANGE IN CASH | -1.02M | 273.00K | -2.44M | -313.00K | -670.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.83M | -5.22M | -5.53M | -6.51M | -9.30M | |||
| Capital Expenditure | -2.00K | -14.00K | -10.00K | N/A | 0.00 | |||
| FREE CASH FLOW | -3.83M | -5.23M | -5.54M | -6.51M | -9.30M | |||
All data in CAD